Podcasts about Attribution

Read the Texas Observer Piece here: https://www.texasobserver.org/ut-system-new-controversial-topics-policy-policing-knowledge/ Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast

In this episode of GTM Live, Carolyn sits down with Matthew Sciannella, VP of Innovation at Refine Labs, for a candid conversation about the flaws of B2B marketing measurement and why so many teams keep fighting the same losing battles.They dig into why attribution has made a generation of marketing leaders worse at their jobs, what great demand generation actually requires (hint: it starts way upstream with product marketing), and why slapping AI onto a broken system just makes the noise louder.Episode highlights:Why attribution doesn't tell you what's actually driving pipeline and how to move toward incrementality testing insteadThe real reason win rates are so low at most companies (and why more pipeline isn't the answer)Why great product marketing is the single biggest common denominator across every high-performing demand program Matt has seenHow AI is disrupting outbound and why scaling a broken motion with AI just makes it worse fasterWhy companies with messy data are the ones struggling most to make AI work for themThe case for measuring brand spend against contribution margin instead of source or attributionWhy fundamentals (e.g. in-person, intentional outreach, real buyer research) are making a comeback in the age of AI noiseIf your pipeline dashboards aren't giving you straight answers, this episode is a good gut check on where to look first.

On December 10th, 1967, a crowd was gathering outside of The Factory in Madison, as Otis Redding was scheduled to play 2 shows there that evening. The Factory was a newer venue in Madison, and Otis Redding was one of the fastest growing musical acts in the world, just coming off his renowned performance at the Monterey Pop Festival earlier in the year.  Otis never played that night, and the tragedy of why will forever hover over the city of Madison like a shadow, also launching Otis into immortality.  Scott and Mickey discuss what happened in Madison over Lake Monona, Otis' personal and musical journey that led him there, and his place in music history.  Hear the story of how one of music's greatest rises to superstardom ever ended on an icy Wisconsin afternoon on Episode 61 of Badger Bizarre: "Otis Redding."    Facebook Twitter Website Email us:  badgerbizarre@outlook.com   Opening Trailer: Ed Gein Sound Byte : "Hard Copy" - Paramount Domestic/CBS Televsion Frank Lloyd Wright and Jeffery Dahmer Sound Byte - WISN 12 News - Milwaukee, WI Jeffery Dahmer Quotes: "Inside Edition"  - King World/CBS Television/CBS Media   Attribution for Music: Trailer: Composer: Adam Phillip Zwirchmayr https://www.pond5.com/ Intro: https://pixabay.com/ Outro: Composer: Viacheslav Sarancha  https://www.pond5.com/   Attribution for logo design: Red Claw Scratch Photo   Sources:   Freeman, Scott - "Otis!: The Otis Redding Story" Lauterbach, Preston - "The Day the Music Died" Memphis Magazine, 2007 Moe, Doug - "Soul Finale" Isthmus Cover Stories, 2017 Wisconsin State Journal - Archives   Songs:  Music samples used under "Fair Use" legal doctrine  Section 107 of the Copyright Act of 1976 (17 U.S.C. § 107)   "Green Onions" - Booker T & the MGs "These Arms of Mine" - Otis Redding "Hard to Handle"  - Otis Redding "Sitting on the Dock of the Bay" - Otis Redding   Please visit our Sponsor:  FrameMakers                

Split in half by a wall of stone, the party faces off against Darivan and his basilisk.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send a text

In dieser Folge sprechen wir mit Raimund Ortner, Head of Business and Wealth bei Coinfinity, über Unternehmer und ihren Blick auf Bitcoin. Tätigen Unternehmen in turbulenten Phasen Panikverkäufe – oder denken sie langfristiger? Warum beschäftigen sich immer mehr Unternehmer mit Bitcoin und wird Bitcoin auch als Marketinginstrument genutzt? Außerdem sprechen wir über den Zeithorizont von Unternehmen und die Frage, ob Unternehmer Bitcoin womöglich besser verstehen als Privatanleger.

Featured on Braille: Problems with Gravity - by Joao Ventura - narrated by Tim Borella No Solution - by Christian Barragan Project ASTROLABE - by Nicolas Van Der Haar Our Audio License AntipodeanSF Radio Show by Ion Newcombe is licensed under CC BY-NC-ND 4.0 Featured Music Gravity by Sanfeel is licensed under a Attribution-NonCommercial-ShareAlike License. Gabriel by Brylie Christopher is licensed under a Attribution 4.0 International License. Through My Astrolabe by Polyphony Più is licensed under a Attribution 4.0 International License. Intro & Outro Music Celestial Navigation by Blue Dot Sessions is licensed under a Attribution-NonCommercial License

In our new episode, I'll be talking about the results of the week, the new attribution settings updates and answering all your burning questions.

"Because the premise of immune checkpoint blockade centers around elevating the immune function, we should always take a great deal of caution around those patients who have high immune risks. Those include patients with autoimmune disorders. That's one of our biggest questions that we ask, usually every consult that we're seeing with solid tumor. 'Do you have any history of autoimmune disorders? Tell me a little bit more about it. Is it being treated? What are your symptoms like?' And then also patients who have undergone organ transplants. Now, interestingly, this does include stem cell transplants," Kelsey Finch, PharmD, BCOP, oncology pharmacist practitioner at Columbus Regional Health in Indiana, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about checkpoint inhibitors. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 20, 2027. Kelsey Finch has disclosed a speakers bureau relationship with AstraZeneca. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to checkpoint inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 273: Updates in Chemotherapy and Immunotherapy Episode 174: Administer Pembrolizumab Immunotherapy With Confidence Episode 139: How CAR and Other T Cells Are Revolutionizing Cancer Treatment ONS Voice articles: Here's Why Oncology Nurses Are Pivotal in Managing Immune-Related Adverse Events Make Subcutaneous Administration More Comfortable for Your Patients Nursing Considerations for ICI-Related Myocarditis Oncology Nurses Navigate the Changing Landscape of Immuno-Oncology Postdischarge ICI Patient Education Eliminates Hospital Readmissions Shorter Administration Times Still Require High-Acuity Care ONS Voice oncology drug reference sheets: Dostarlimab-Gxly Nivolumab and Hyaluronidase-Nvhy Nivolumab and Relatlimab-Rmbw Pembrolizumab and Berahyaluronidase Alfa-Pmph Retifanlimab-Dlwr Toripalimab-Tpzi ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Guide to Cancer Immunotherapy (second edition) ONS course: ONS/ONCC® Chemotherapy Immunotherapy Certificate™ Clinical Journal of Oncology Nursing articles: Immune Checkpoint Inhibitor–Related Myocarditis: Recognition, Surveillance, and Management Immune Checkpoint Inhibitor Therapy: Key Principles When Educating Patients Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers ONS Huddle Cards: Checkpoint Inhibitors Immunotherapy ONS Learning Libraries: Genomics and Precision Oncology Learning Library Immuno-Oncology Learning Library Drugs@FDA package inserts National Comprehensive Cancer Network homepage OncoLink: All About Immunotherapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Before immune checkpoint blockade, the two-year overall survival rate in metastatic melanoma was hovering around 10%. After these agents came to market, depending on the trial and the agents used, that number actually increased to about 50%–65%. So, five times the amount of patients were actually living at the two-year mark. Not surprisingly, studies then exploded across several tumor types, leading to approvals in all sorts of cancers, mostly in the solid tumor. But there are a couple hematologic as well. Lung cancer, kidney cancer, head and neck, Hodgkin lymphoma, hepatocellular, the list goes on. So, it's really just transforming the stage IV setting across all tumors, specifically from uniformly fatal prognosis to one where durable responses and long-term survival is also possible." TS 3:03 "There are four different mechanisms officially being used in therapies that are approved by the U.S. Food and Drug Administration (FDA). Those are cytotoxic T-lymphocyte–associated protein 4, programmed cell death protein 1, and programmed cell death ligand 1, which I'm counting as two different mechanisms, even though they somewhat work together. And lymphocyte-activation gene 3 is the fourth one that's in there. So, all these mechanisms impact the T cell in our immune system. The T cell is traditionally responsible for protecting our body from harmful things like bacteria, viruses, and cancer. When the tumor binds to cytotoxic T-lymphocyte–associated protein 4 receptors, that happens on the T cell itself. And that inhibits the activation of the T cells, essentially allowing that tumor to then live. So when developing medications that block this receptor, they noted an added benefit that it actually increased the T-cell proliferation as well as keeping that T cell active. So not only are we not blocking the T cells, we're making them more productive." TS 5:38  "If you have a chance of any sort of tissue rejection, specifically with allogeneic stem cell transplants or where we see that focusing on it, there's a little bit of controversy, mixed bag on opinions as far as autologous stem cell transplants. But it's best to at least exercise a little bit of caution. If they have a chance of organ rejection, is that worth the risk of the therapy that we're looking to give? And then, patients with HIV, any sort of immunologic concerns at baseline that we could potentially worsen." TS 14:37 "As a rule of thumb, with immune checkpoint blockade, regardless of what mechanism you're looking at, if something in your body can get inflamed, that can wind up as an adverse event. So, whenever I talk to my patients, the key word is anything ending in '-itis.' ... The most common adverse events that we end up seeing are dermatitis and hypothyroidism. Immune checkpoint blockade can cause both hyper- and hypothyroidism. Very often, we actually start in the hyper- and then end up, for lack of better words, burning out the thyroid, ultimately leading to a sustained hypothyroidism." TS 18:34 "The half-life of immune checkpoint inhibitors is usually around 30 days, meaning that once these agents are given, the drug will be in the patient's system for up to five months. Specifically, it will probably build month to month, so often we don't even see a lot of our adverse events until month three or four. Usually, when we're that far into treatment, we're not looking for new adverse events in things like chemotherapy. But these drugs do build over time." TS 24:28 "As far as safe handling is concerned, these agents are not chemotherapy. That makes drug compounding and administration pretty straightforward. When looking at the follow-up care, the most important thing, in my opinion, is to engage in meaningful dialogue with your patients. A lot of the side effects can be nonspecific. So, really listening to the patient and evaluating changes in their lifestyle, I think it'll get you far. We usually hark in on the new, worsening, or persistent whenever we're talking to patients because they'll be looking for things as well. So, just having a dialogue of how their life has changed can certainly help." TS 26:17

Upload in Progress ep.815 R. F. Daniels (they/he) is a queer nonbinary writer and software engineer living and working in Finland. When they aren't arguing with computers or getting lost in speculative worlds, they can be found painting, composing sad music, and spending time with their cats. Their short fiction has appeared or is forthcoming in State of Matter, Club Chicxulub, and Common Bonds 2. You can find them online at www.rfdaniels.com or @rfdwrites.bsky.social.   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords

In this first episode from Vietnam, Laura and Carrie land in Ho Chi Minh City (aka Saigon) and step straight into the chaos — jet lagged, wide-eyed, and trying to cross streets filled with rivers of motorbikes. They explore its contradictions: honking traffic and quiet hidden alleyways, glass skyscrapers and corrugated tin rooftops. These are their first impressions of Vietnam — loud, complicated, and unforgettable.Then we travel to the Cu Chi Tunnels, a 250-kilometer underground network used by Vietnamese soldiers during the Vietnam War (or the American War, depending on your perspective.) Standing where history actually happened makes the conflict feel real and complex. We learn about French colonialism, Cold War politics, Agent Orange, unexploded bombs, and the lasting impact of war that continues today. We crawl into tunnel entrances, watch propaganda films in a dirt-walled bunker, and confront what it feels like to be an American visitor in a place shaped by that history.This episode is part travel diary, part history lesson, and part personal reflection — and just the beginning of our Vietnam journey.Musical Credits:Get Away In La, by Western Youths, Revolution Fever by Klaatu Verada Necktie, Music provided by: Slipstream Music Xanadon't by Mystery Mammal is licensed under a Attribution License. Black Hawk City Fly-Over.wav by djfinski  License: Attribution 3.0 Whispers in the Trees by Greg Kirkelie is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License.  My Native Land by Le Chaos Entre 2 Chaises is licensed under a Attribution 4.0 International License. Support the showWant to support the podcast? Go to Laura's Patreon site to see photos from the episode, maps of places she talks about and you can become a patron too!Follow the show on instagram or facebook. Buy any of these products that I fully stand behind- and I'll earn a commission. Buy cute sustainable bags at: https://torrain.org/ Use Promo code: TRAVELALONG to get 15% off. Buy matcha at: https://mantramatcha.com/ Use Promo code: TRAVELALONG to get 15% off. Buy sustainably produced coffee: https://www.afueracoffee.com/ Enter promo code: TRAVELALONG for 15% off. Flowers by Cedric Galke x Fachhochschule Dortmund is licensed under a Attribution 4.0 International License.

Is your marketing data actually lying to you? In this episode, attribution expert Jeff Greenfield, founder of Provalytics and former CEO of C3 Metrics, breaks down why last-click attribution is costing brands millions, what really changed when cookies disappeared, and how to measure channels like CTV and podcasts where nobody clicks.We cover GA4's biggest blind spots, the truth behind Facebook and Google's walled garden data, and why pharma marketers face the hardest measurement challenges in the industry. Whether you're a CMO, performance marketer, or analytics lead , this is the conversation that will change how you think about measurement.Jeff is an entrepreneur, advisor, and disrupter with three decades of strategy, growth and marketing leadership. Jeff is currently building the next generation of AI-Driven Attribution as the co-founder and CEO of Provalytics which is a 'cookie-less' attribution & measurement solution which enables marketers to prove the impact from upper funnel channels like CTV and grow their budgets.

Send a textEver wonder how attribution is measured for Amazon ads? This video breaks down common questions about the transparency of Amazon ad attribution, guiding sellers through understanding this crucial aspect of their campaigns. Learn about effective marketing attribution and refine your amazon advertising strategy for better results. Gain insights into different attribution model frameworks and their impact on marketing measurement. Wasting ad spend? Book a PPC strategy call here:  https://bit.ly/4jMZtxu#AmazonAds #AmazonPPC #AmazonAttribution #AmazonFBA #ecommercemarketing -------------------------------------------------------------------------Want free resources? Dowload our Free Amazon guides here:Amazon Proft Margin Defense 2026: https://hubs.ly/Q042trRH0Amazon PPC Guide 2026 is here!: https://bit.ly/4lF0OYXAmazon SEO Toolkit 2026: https://bit.ly/4oC2ClTAmazon Seller Strategy Report 2026: https://bit.ly/3YN1RME2026 Ecommerce Website & SEO Readiness Checklist: https://hubs.ly/Q040Jg0M0Amazon Crisis Kit: https://bit.ly/4maWHn0________________________________Timestamps:00:00 – What Is Amazon Ad Attribution?00:47 – Types of Amazon Ads Explained01:12 – First Touch vs Last Touch Attribution02:08 – Why Amazon Uses Last Click02:37 – Attribution Windows and Time Frames02:57 – 7-Day Window for Sponsored Products03:40 – 14-Day Window for Sponsored Brands and Display04:02 – Click vs View Attribution (VCPM)04:43 – Auxiliary Purchases and Brand Halo Effect05:42 – How to Pull Attribution Reports in Seller Central06:34 – Sponsored Brand Attributed Purchases07:15 – Sponsored Display Purchased Product Report________________________________Follow us:LinkedIn: https://www.linkedin.com/company/28605816/Instagram: https://www.instagram.com/stevenpopemag/Pinterest: https://www.pinterest.com/myamazonguys/Twitter: https://twitter.com/myamazonguySubscribe to the My Amazon Guy podcast:My Amazon Guy podcast: https://podcast.myamazonguy.comApple Podcast: https://podcasts.apple.com/us/podcast/my-amazon-guy/id1501974229Spotify: https://open.spotify.com/show/4A5ASHGGfr6s4wWNQIqyVwSupport the show

Episode 28- The path is set forward. To avoid chaos in the city a deal must be struck. An actual play, tabletop role-playing game that uses the Pathfinder 1E rule-set. The epic story follows the brave players through a unique dark fantasy world. The Heroes trials and tribulations will have them brought face to face with demons, devils, angry spirits, the occult, and more. The story takes place in the dark fantasy world of Mel'Herron. Our heroes are brought together by mysterious circumstances leaving them with more questions than answers. An ever-present dark force seems to be lurking in the shadows seeking the party for reasons they must figure out or be swept up by the coming storm. Please like and follow !!! =) Marty is the Dungeon Master, Bobby plays Uri, Wes plays Rein, Derek plays Solaris, Morris play Lirium, Marcus plays Torad Follow us on Twitter: @dicebargaming1    Facebook: The Dice Bar Gaming Podcast Music by: https://www.fesliyanstudios.com Scott Buckley  www.scottbuckley.com.au. Kevin MacLeod Link: https://incompetech.filmmusic.io/song/5048-stay-the-course License: https://filmmusic.io/standard-license. Paid license from: www.epidemicsound.com March of Midnight by Scott Buckley | www.scottbuckley.com.au Music promoted by https://www.chosic.com Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/ Unseen Horrors Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0/ Music promoted by https://www.chosic.com/ For world info- https://www.worldanvil.com/w/mel-herron-bruehawk Friends of the podcast: Bored Online? Board Offline!- https://www.youtube.com/channel/UCVmlVsZVlruYWnIYd42iBhw Game Knight Hero Podcast- https://podcasts.apple.com/us/podcast/game-knight-heroes/id1552887060 Deadlands by Kerri Smith- https://www.youtube.com/channel/UCAVrPUutK3IvxLWDKaN3UgQ **Episodes contain adult content. “a mature Podcast”**

Welcome to another edition of Bettin N Boozin on the HHH Racing Podcast! This week we head back to South Florida for Gulfstream Park Sprint Stakes Day and we will handicap the late Pick5 sequence sponsored by TwinSpires! Who do we think wins? Find out in this episode!Come for the handicapping, stay for a drink!It's a great day to make some money, we are always Boozin N Not Losin! Stay tuned for GREAT ANALYSIS and see you in the LIVE CHAT!Please Like, Subscribe and comment below the video player your opinions, we would love to hear from you and respond to every one!__________________________________________________________________NORMAL PODCAST SCHEDULE:Tuesday Night @9:30pm EDT: Pacific Horseplayers with Noah, Ryan and JacksonWednesday Night @8pm EDT: Bettin N Boozin with Kyle, Andrew and Patrick Thursday Night @8pm EDT: Picks and Ponies with Howard, Pete and Paul(MORE COULD BE ADDED AT ANY TIME, PLEASE SUBSCRIBE AND HIT THE NOTIFICATION BELL TO BE NOTIFIED OF ALL LIVESTREAMS/VIDEOS!)__________________________________________________________________Go to our website: https://www.hhhracingpodcast.com__________________________________________________________________Podcast Twitter/X: @hhhracingpodHost:Kyle Roscoe: X - @APRoscoeKCo-Hosts:Andrew Rdesinski: X - @phillyboy415Patrick Kuenzel: X - @PatrickKuenzelIntermittent Co-Hosts:Noah Meagher: X - @NoahMeagCharlie Freeman: X - @CFREE316_________________________________________________________________Horse Racing Promotions: Subscribe to the excellent, informative, AFFORDABLE and profitable "Power Picks" Tip Sheet! Please go to: www.patreon.com/hhhracingpodcast Fantastic ABC P4 and P5 grids, along with Spot Plays and Price Plays provided that currently has an ROI around $2.15 (national average is $1.60). Picks arrive via email every Sat. morning for that day's races. Purchase your Power Picks NOW and make 2024 your best handicapping year ever! www.patreon.com/hhhracingpodcast__________________________________________________________Bettin N Boozin Logo by Erik Morgan (Instagram @erik_mgn10)__________________________________________________________Intro Music:Superepic by Alexander Nakarada | https://creatorchords.com/Music promoted by https://www.chosic.com/free-music/all/Attribution 4.0 International (CC BY 4.0)https://creativecommons.org/licenses/...___________________________________________________________Horse Racing Intro Background Video graciously provided by @Fastec ImagingLink to video: https://www.youtube.com/watch?v=UfuI_TiKDYI&t=32s___________________________________________________________LINK TO A GREAT HORSE RACING OWNERSHIP OPPORTUNITY WITH CROWNS WAY RACING: https://sites.google.com/view/crowns-way-racing___________________________________________________________LINK TO SIGN UP TO BETUS -- (USE CODE RACING3H WHEN DEPOSITING MONEY)https://www.betus.com.pa___________________________________________________________#horseracing #horseracingtips #GulfstreamPark #GulfstreamParkPicks

Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast

19:09 – Welcome a new show to Onsug – Now of Now, by Sinister Purpose. A story of moments in a moment. Sometimes work/life balance has to happen on the job. License for this track: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Attribution: by Frank Edward Nora – more info at onsug.com

In this episode of The Podcast Advertising Playbook, host Heather Osgood sits down with Bryan Barletta, Founder of Sounds Profitable, to discuss how podcast attribution has evolved and what measurement really looks like in a world where audio and video are converging. Attribution in podcasting has come a long way, but it is still widely misunderstood. Bryan shares where measurement is genuinely improving, why some reporting may appear lower than expected, and how advertisers can think more strategically about evaluating performance across platforms like Spotify Video, YouTube, and traditional audio. In this episode, we discuss: How podcast attribution has improved and what is driving greater advertiser confidence What advertisers often misunderstand about podcast measurement and performance data The tradeoffs that come with video podcasting and how it impacts reporting How to think about attribution when campaigns run across audio, Spotify Video, and YouTube What “good enough” attribution looks like and what the future of measurement may hold If you are trying to better understand podcast performance and make smarter decisions with attribution data, this episode offers practical guidance and a clear view of where the industry is headed.

Sony just built a tool that can look inside any AI-generated song and tell you exactly which artists it borrowed from — down to a percentage.Think outputs like: 30% Beatles. 10% Queen. For any AI-generated track.Most people are reading this as a music story. I'm reading it as a preview of where every creative industry is headed. The same logic that lets Sony fingerprint an AI song is coming for AI-written copy, AI-generated images, and AI-produced video.The wild west window is closing. Are you ready?In this episode: • How Sony's system works (and what happens when AI companies don't cooperate) • Why major labels are going from victims to tollbooth operators• What this means for solo creators and brand content teams right now. • Three lessons for leaders navigating this shift The question you need to answer before attribution tech lands in your industryLesson 1: Fighting the technology is almost always the wrong move. Lesson 2: Attribution will reshape what AI-generated content costs. Start asking your team what your AI tools were trained on. Lesson 3: Your authentic voice cannot be fingerprinted back to a training dataset. That is your competitive advantage.Source: TechSpot — Sony's New System Can Identify Original Tracks Inside AI-Generated MusicSubscribe to the AI for Everyone newsletter for weekly insights built for executives, educators, and entrepreneurs. No hype. Just what matters and what to do about it.

Glad to have you listening with us today! Join Ms. Andy as she reads a book from here in the Library! This author is fairly popular, and we were curious what they were like. Which got us thinking, maybe we could share a bit with you too! Today's book is "A Dangerous Man" by Robert Crais, which we read just a bit of here. We hope you enjoy this sneak peak, and as always if you enjoy the story then we invite you to visit your local library and ask them to reserve it for you!- Check out the Library Systems official website where you can find links to free resources, school and career guides, and news about our upcoming events! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.pawls.org/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ -Follow us on YouTube and enjoy our backlog of digital story hours and other great content! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.youtube.com/@pawls365⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Original background track is The Talons Of Adventure, The Antlers Of Romance by Doctor Turtle, music from the freemusicarchive.orghttps://freemusicarchive.org/music/Doctor_Turtle/none_given_1561/Doctor_Turtle_-_You_Um_Ill_Ah1/The Talons Of Adventure, The Antlers Of Romance by Doctor Turtle is licensed under a Attribution 4.0 International License.Alterations were made by us to make it fit the length of our content.#library #books #pawlskids #kidsstorytime

This episode is brought to you by B2B Better. Stop sending "just checking in" emails. We build owned media systems that give your sales team actual reasons to reach out, turning podcasts into sales enablement assets that move deals forward. If your sales reps send "just checking in" emails to prospects who've gone quiet, this episode explains why those fail and what to do instead. Host Jason Bradwell breaks down how to create milestone moments, legitimate, value-led reasons to reach out through long sales cycles without sounding desperate. Jason's core point is clear: most B2B sales cycles are brutally long, but sales teams don't know how to stay present without being annoying. The traditional approach fails. Discovery call, proposal sent, then "just checking in" emails with no response. Twelve months later, the prospect went with a competitor because "you didn't understand our business." After month two, you had nothing valuable to say. 95% of B2B Better's clients have sales cycles over six months. And 95% of your customers are out of market at any given time. Your job is to stay present so when they flip to being in market, they think of you first. Most owned media falls apart here. Marketing creates beautiful content. Sales sees it but has no idea how to use it in actual sales motion. Marketing measures downloads. Sales measures meetings. Different languages, different outcomes. Milestone moments fix this. Month one: send proposal plus a podcast clip addressing their exact challenge. Month three: benchmark report. Month four: webinar invite. Month five: customer story. Month six: check in with context. Months seven to twelve: new episodes create new reasons to reach out. Month eighteen: deal closes because you felt like a partner. B2B Better's sales enablement kits deliver three clips with email copy, key graphics, follow-up sequences, and tags showing which funnel stage each piece serves. One innovation: sales stitch videos where reps record 30-second reactions to clips. Personal brands beat company brands these generate thousands of views when originals get hundreds. This works with three things: marketing-sales alignment through quarterly planning, infrastructure for sales to contribute to production, and attribution through CRM tracking plus conversations about where content surfaces in deals. Chapter Markers 00:00 - The "just checking in" problem that kills deals 01:00 - Context on long sales cycles and 95% out-of-market buyers 02:00 - Why owned media strategies fall apart at sales activation 03:00 - Traditional approach: proposal to dead deal in 12 months 04:00 - Milestone moments approach: 18-month cycle done right 06:00 - What qualifies as a milestone moment 07:00 - Timing and sequencing content to the buyer journey 08:00 - Sales enablement kit components 09:00 - Tags and metadata for searchable, attributable content 10:00 - Sales stitch videos: personalising content at scale 11:00 - Why personal brands beat company brands in B2B 12:00 - Three requirements: alignment between teams 13:00 - Infrastructure for sales to contribute to production 14:00 - Attribution: quantitative and qualitative tracking 15:00 - The challenge: audit your last five gone-quiet emails Useful Links Connect with Jason Bradwell on LinkedIn Read the Ehrenberg-Bass 95-5 rule research Explore HubSpot CRM for tracking content touches Check out Salesforce CRM Explore B2B Better website and the Pipe Dream podcast 

Input geben - Networking starten!Suchmaschinen fühlen sich heute wie Gespräche an – und genau dort müssen wir als Marke stattfinden. Gemeinsam mit Tonio Meier von Guuru gehen wir der Frage nach, warum echte Nutzerstimmen in ChatGPT, Gemini und Perplexity so stark wirken und wie wir diese Kraft gezielt für mehr Sichtbarkeit, Vertrauen und Umsatz nutzen. Statt KI-Textfabriken setzen wir auf Community: authentische Bewertungen, präzise Antworten und konkrete Erfahrungen, die Sprachmodelle als zuverlässige Signale erkennen und zitieren.Wir zeigen, wie sich aus Chats und Diskussionen hochwertige Snippets extrahieren lassen, die sich auf Produktseiten einbetten und sauber strukturieren: mit Datum, Produktbezug, Kurzfazit und klarer Autorenschaft. LLMs bevorzugen aktuelle, menschliche und spezialisierte Inhalte – das macht Freshness, Expertise und transparente Profile zu Pflicht. Der Effekt ist messbar: weniger Streuverlust, qualitativere Klicks, mehr Conversion. Gleichzeitig sinken Supportkosten, wenn How-to-Antworten der Community über KI-Tools als Self-Service gefunden werden. Wir beleuchten die Tücken der Attribution und erklären, welche Indikatoren wirklich zählen, wenn Referrals aus KI-Gesprächen unsichtbar bleiben.Spannend wird es beim Branchenblick: Während große Banken bei generischen Fragen dominieren, gewinnen Nischenanbieter mit klarer Positionierung die spitzen Suchabsichten – etwa bei Mobilität oder Nachhaltigkeit. Das Muster bleibt gleich: echte Stimmen, saubere Struktur, kontinuierliche Aktualisierung. Ob Retail, D2C oder Finance – wer Community ernsthaft fördert, liefert die Art Inhalte, die LLMs schätzen und Kundinnen und Kunden vertrauen. Hör rein, hol dir die Taktiken für KI-Sichtbarkeit mit Substanz und sag uns: Wo aktivierst du deine stärksten Stimmen?Abonniere den Podcast, teile die Folge mit deinem Team und hinterlasse eine Bewertung, wenn dir die Einsichten geholfen haben. So bleibt unsere Community sichtbar – auch in den KI-Gesprächen von morgen. Support the showVielen Dank an unsere Starken Podcast-Partner: Solunex: Der Schwerpunkt von Solunex liegt in der Unterstützung unserer Kunden im effizienten und automatisierten Verarbeiten und erzeugen von Kundenkommunikation. Dabei decken wir sowohl die Eingangsseite ab (Input Management), wobei Automatisierung und Unterstützung der Kundenteams durch den gezielten Einsatz von AI im Vordergrund stehen. Auf der Ausgangsseite (Output Management), steht ebenfalls die Automatisierung im Fokus, sowie die Nutzung sämtlicher Kontaktkanäle zwischen Kunden und Endkunden (Omnichannel Management). Vor über 35 Jahren gegründet, verfügt das Team von Solunex über langjährige Erfahrungen aus erfolgreichen Kundenprojekten, basierend auf hervorragender technischer Umsetzungskompetenz. Solunex unterstützt die Kunden über den gesamten Lebenszyklus einer Lösung aktiv und zuverlässig. https://www.solunex.ch/ AlpineAI: AlpineAI ist ein innovatives Schweizer KI-Unternehmen, das sich auf sichere und datenschutzkonforme KI-Lösungen für Unternehmen spezialisiert hat. Ihr Hauptprodukt, SwissGPT, ist eine Schweizer Version von ChatGPT, die höchste Standards beim Daten- und Geheimnisschutz gewährleistet, indem alle Informationen in Schweizer Rechenzentren verarbeitet werden. AlpineAI versteht sich als Innovationskatalysator für die KI-Transformation und arbeitet daran, Unternehmen durch massg...

Marketing attribution often feels like a guessing game where everyone just ends up giving credit to Google Search. Jay Schwedelson connects with Daniel Murray from The Marketing Millennials to break down why you should treat attribution data as a directional compass rather than a precise GPS. They discuss practical ways to validate your data, including the power of holdout groups and geo-testing, plus a random side conversation about whether Olympic curlers are actually the best athletes in the world.Follow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.Best Moments:(01:50) Why attribution should be viewed as a compass instead of a turn-by-turn GPS(02:22) The problem with giving Google Search all the credit for last-touch conversions(03:10) How to set up a holdout group to measure the true lift of your campaigns(04:09) Using geo-based testing to see if specific channels are actually driving growth(04:45) Why it is a red flag if one channel claims 100% of the credit in a multi-touch world(05:15) The surprisingly effective "How did you hear about us?" form field strategy(06:40) A hot take on whether curling athletes are actually the best in the worldCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out April 21, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206

The Unexpected Morning ep.814 Rick Kennett is a life long resident of Melbourne, Australia. While a bounder and a cad to the populace in general he is nevertheless a good friend to next door's white Tom who, in a fit of originality, he calls Cat. Rick was recently published in the Canadian magazine Weird Horror, and a reissue of his co-authored Carnacki the Ghost Finder pastiches, 472 Cheyne Walk, will be issued soon from Cathaven Press. "The Unexpected Morning" has a lot more reality in it than he cares to admit. Including a real ghost.   More TTTV stories by Rick Kennett: https://talltaletv.com/tag/rick-kennett/   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords

The party meets Darivan, the leader of the Cult of the Bloom.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send a text

Attribution is one of the most talked-about topics in marketing…and also one of the most misleading. Jay and Daniel explain why most attribution models are basically garbage, especially last-touch attribution, and why marketers keep over-investing in channels like Google Search simply because they get the final click. Jay walks through one of the most underused measurement tactics in marketing: holdout groups, where you intentionally exclude part of your audience from campaigns to measure real lift. Daniel adds the simplest attribution hack of all: just asking customers where they heard about you. If you're tired of dashboards that tell you what you want to hear instead of what's real, this episode Follow Jay: LinkedIn: https://www.linkedin.com/in/schwedelson/ Podcast: Do This, Not That Follow Daniel: YouTube: https://www.youtube.com/@themarketingmillennials/featured Twitter: https://www.twitter.com/Dmurr68 LinkedIn: https://www.linkedin.com/in/daniel-murray-marketing Sign up for The Marketing Millennials newsletter: https://themarketingmillennials.com/ Daniel is a Workweek friend, working to produce amazing podcasts. To find out more, visit: https://workweek.com/

"It's important to clarify that most patients will experience and at least some side effects—and often several. So prevention really means reducing severity, complications, and long-term impact rather than avoiding side effects altogether. This process starts before radiation begins and continues throughout the treatment and includes dental evaluation, baseline swallowing assessments, and thorough patient education," ONS member Astrid Amoresano, RN, OCN®, lead oncology nurse specialist at New York Proton Center in New York, NY, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about side effects of radiation for head and neck cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 13, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to radiation side effects in people with head and neck cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Cancer Symptom Management Basics series Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 128: Manage Treatment-Related Radiodermatitis With ONS Guidelines™ ONS Voice articles: Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education IMRT Shows Similar Quality-of-Life Outcomes to Proton Therapy in Head and Neck Cancer How to Handle Even the Worst Radiation Therapy Side Effects ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Radiation Therapy Certificate™ ONS Oncology Symptom Management Clinical Journal of Oncology Nursing articles: The Role of Advanced Practice Providers in Radiation Oncology in 2025 Systematic Review of Malnutrition Risk Factors to Identify Nutritionally At-Risk Patients With Head and Neck Cancer Effects of a Nurse-Initiated Telephone Care Path for Pain Management in Patients With Head and Neck Cancer Receiving Radiation Therapy Radiation-Induced Skin Dermatitis: Treatment With CamWell® Herb to Soothe® Cream in Patients With Head and Neck Cancer Receiving Radiation Therapy ONS Radiation Learning Library ONS Symptom Intervention Resources ONCC: Radiation Oncology Certified Nurse (ROCN™) American Cancer Society CA: A Cancer Journal for Clinicians article: American Cancer Society Head and Neck Cancer Survivorship Care Guideline Cancer Survivors Network: Head and neck cancer Head and neck cancer resources Radiation therapy resources American Society of Radiation Oncology National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) National Comprehensive Cancer Network To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Many tumors in the region are very radiosensitive, and radiation can be used either as definitive treatment or after surgery to reduce the risk of reoccurrence, but in many cases, radiation is combined with chemotherapy to improve local control. Because so many vital structures are located in this small complex area, radiation allows us to treat the cancer while minimizing the need for extensive or disfiguring surgery." TS 2:40 "The most common acute side effects of head and neck radiation: effects to the mouth, the throat, the skin, and the energy level. Patients often experience a mucositis, pain or sore throat, difficulty swallowing, dry mouth, or thick saliva, and taste changes. Skin irritation and redness in the treatment field is also common and can progress to dry and moist desquamation. Fatigue is another frequent side effect and tends to build as treatment progresses. Emotional and psychological distress are also very common in this patient population and can have an impact on daily function and quality of life. Side effects usually develop gradually, often beginning in the second and third week of radiation and may be more severe or have an earlier onset in patients receiving concurrent chemotherapy." TS 4:02 "Pain management is essential so patients can continue eating and drinking. Supporting the energy level and maintaining hydration are also key, as fatigue and dehydration can significantly worsen other side effects. Oral care protocols help manage mucositis and nutrition support may include supplements or enteral feeding if needed." TS 11:24 "Sexual health might not be the first thing nurses think of in regard to head and neck radiation. … But even though radiation for head and neck cancer doesn't involve the reproductive organs, it can still have a significant impact on sexual health and intimacy. Like fatigue, pain, dry mouth, changes in speech and visible changes in appearance can all affect body image and relationships." TS 14:52 "One of the common misconceptions is that side effects end when radiation ends. In reality, some effects peak afterward or become long term. Xerostomia, or dry mouth, and taste changes are good examples. While some patients improve, others adjust to a new normal where dry mouth and altered taste are permanent." TS 19:53

Jeffrey Dwoskin's career exemplifies strategic problem-solving through direct market experience. From educating late-1990s clients about websites to building Stampede Social, he consistently identified emerging technologies and learned new skills whenever markets demanded them. Each venture built upon previous knowledge, creating a cohesive journey driven by genuine curiosity. His competitive advantage lies not in staying in one domain but in recognizing opportunities at the intersection of passion and market need, then executing with technical depth. Jeffrey's entrepreneurial insight came from firsthand experience at the agency level working with major brands and influencers on Instagram campaigns. He created Stampede Social to consolidate fragmented data across platforms, enabling creators to identify their most valuable fans, track conversions, and understand audience overlap—transforming raw engagement into measurable business results. His approach democratized enterprise-level analytics for mid-career creators, proving that sustainable success emerges from solving problems you've genuinely experienced rather than imagined ones. Jeffrey Dwoskin's fundamental insight for creators is this: understand algorithms but prioritize authenticity over trends. Ready to consolidate your multi-platform presence and track metrics that matter? Visit Stampede Social—the fastest way to get your fans directly to your content without overwhelm. Everything you need to increase engagement on Instagram is now in one central place, designed to help you amplify your authentic voice and measure what actually drives results. For the accessible version of the podcast, go to our Ziotag gallery.We're happy you're here! Like the pod?Support the podcast and receive discounts from our sponsors: https://yourbrandamplified.codeadx.me/Leave a rating and review on your favorite platformFollow @yourbrandamplified on the socialsTalk to my digital avatar Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

(Presented by Thinkst Canary: Most Companies find out way too late that they've been breached. Thinkst Canary changes this. Deploy Canaries and Canarytokens in minutes and then forget about them. Attackers tip their hand by touching 'em giving you the one alert, when it matters. With zero admin overhead and almost no false-positives, Canaries are deployed (and loved) on all 7 continents.) Three Buddy Problem - Episode 85: Top stories this week include drone incursions over El Paso and the murky line between cartel activity, anti-drone tech testing, and full-blown hybrid warfare; updates on the Notepad++ supply chain fallout; Microsoft's zero-day treadmill and AI-enabled attack surfaces; and Apple's “extremely sophisticated” iOS exploits. Plus, Europe's growing appetite for offensive cyber, Palo Alto and the uncomfortable politics of cyber attribution, Singapore on telco intrusions, and the economics of end-of-life infrastructure. Cast: Juan Andres Guerrero-Saade, Ryan Naraine and Costin Raiu.

Send a textWe discuss optimizing your Amazon ad spend by structuring campaigns to account for attribution delays, especially between sponsored display and sponsored products. Understanding how Amazon attribution works is crucial for effective Amazon PPC. This approach helps in refining your strategies and improving overall campaign performance on Amazon.Amazon advertising performance often looks wrong due to attribution delays across sponsored products and sponsored display campaigns. This video explains how buyer behavior, reporting delays, and funnel position affect campaign results and optimization timing. Learn when to optimize existing campaigns, when to test new structures, and why turning off working keywords can hurt results.Get direct answers on fixing attribution delays and campaign structure before bad data costs real revenue: https://bit.ly/4jMZtxu#AmazonAds #SponsoredProducts #SponsoredDisplay #AmazonPPC #AmazonSellers--------------------------------------------------------------------------Want free resources? Dowload our Free Amazon guides here:Amazon PPC Guide 2026 is here!: https://bit.ly/4lF0OYXAmazon SEO Toolkit 2026: https://bit.ly/4oC2ClTAmazon Seller Strategy Report 2026: https://bit.ly/3YN1RME2026 Ecommerce Website & SEO Readiness Checklist: https://hubs.ly/Q040Jg0M0Q4 Selling Playbook: https://bit.ly/46Wqkm3Amazon Crisis Kit: https://bit.ly/4maWHn0Timestamps:00:22 – Sponsored Products vs Sponsored Display behavior01:05 – Why attribution delays happen on Amazon01:55 – How reporting delays affect optimization timing02:16 – Vendor Central vs Seller Central bid changes02:52 – Why suggested bids should not be trusted03:00 – Optimize existing campaigns vs restructuring03:38 – Testing keywords without killing performance________________________________Follow us:LinkedIn: https://www.linkedin.com/company/28605816/Instagram: https://www.instagram.com/stevenpopemag/Pinterest: https://www.pinterest.com/myamazonguys/Twitter: https://twitter.com/myamazonguySubscribe to the My Amazon Guy podcast:My Amazon Guy podcast: https://podcast.myamazonguy.comApple Podcast: https://podcasts.apple.com/us/podcast/my-amazon-guy/id1501974229Spotify: https://open.spotify.com/show/4A5ASHGGfr6s4wWNQIqyVwSupport the show

Dr. Ryan McGeough is back! We're unpacking what happens when plans don't go as planned—and how that slowly erodes trust in ourselves, our follow-through, and even other people. Here's what we're covering: Why broken micro-commitments chip away at self-trust The difference between self-confidence (broad) and self-efficacy (skill-specific) Attribution theory: Do you blame yourself or circumstances when goals fail? How the US became a low-trust culture ("stranger danger" anyone?) Hannah Arendt on forgiveness (breaking the past) and promises (building the future) Ryan's morning hack: Headspace before scrolling My Instagram/Facebook sabbatical experiment The trust erosion cycle: You make plans → things don't go as planned → you stop trusting that planning matters → you break commitments to yourself → self-trust crumbles. The key insight: Some people fail at goals and think "bad goal, bad circumstances." Others internalize it: "I'm a piece of crap." Attribution theory explains why—and how to change the pattern. Ryan's trust lesson: That 6am lake running goal? Bad goal. Not because he can't accomplish things—because it didn't fit his reality. Now he knows which goals are longer shots and builds more structure around those. The Valentine's Day truth: Annual goal-setting together builds trust beyond reliability. When your partner actively supports what matters to you, it creates space to take risks and pursue things that excite you—even if they don't match your 10-year-old plans. Mentioned in this episode: Attribution theory Hannah Arendt's Between Past and Future Headspace app Self-efficacy vs. self-confidence Connect with me: Email: support@plangoalplan.com Facebook Group: Join Here Website: PlanGoalPlan.com LinkedIn: (I post most here!) www.linkedin.com/in/danielle-mcgeough-phd-

Of Monsters and Mushrooms, Ch. 13 (book 1 NEW) ep. 813 A Really Dumb Idea NOTE: This is a rewrite of book 1. Originally, 'Of Monsters and Mushrooms' was supposed to be a multi-part short story that transformed halfway through into a novel. This left the plot (and the voice acting, to be honest) lacking. We decided to go back and completely rewrite book one to fix any plot holes and bring the quality in line with the rest of the series. Listen to the new book one playlist here https://talltaletv.com/series-of-monsters-and-mushrooms-new/ or Listen to book one (NEW!) https://talltaletv.com/series-of-monsters-and-mushrooms-new/ Listen to book two http://talltaletv.com/series-of-tyrants-and-teakettles/ Listen to book three http://talltaletv.com/series-of-bandits-and-bad-magic/ Listen to book 3.5 https://talltaletv.com/series-an-interlude-of-intrigue/ Listen to book four https://talltaletv.com/series-of-portals-and-portents/ Listen to book five https://talltaletv.com/series-of-risk-and-relativity/   Listen to the original book one http://talltaletv.com/series-monsters-mushrooms/   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords

In dieser Folge sprechen wir mit Fab – unserem allerersten Gast – über Vertrauen, Wahrnehmung und den Blick auf Bitcoin. Wir diskutieren, ob Fundamentaldaten oder doch der Preis das entscheidende Vertrauenselement sind, wie Bitcoin in den Mainstreammedien dargestellt wird und was das mit der öffentlichen Wahrnehmung macht. Zum Abschluss wagen wir noch einen Blick nach vorn: Welche Prognosen gibt es für Folge 400?

"You also want to deal with patient preferences. We do want to get their disease under control. We want to make them live a long, good quality of life. But do they want to come to the clinic once a week? Is it a far distance? Is geography a problem? Do they prefer not taking oral chemotherapies at home? We have to think about what the patient's preferences are to some degree and kind of incorporate that in our decision-making plan for treatments for relapsed and refractory myeloma," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about multiple myeloma treatment considerations. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 6, 2027. Ann McNeill has disclosed a speakers bureau relationship with Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of multiple myeloma. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 395: Pharmacology 101: Monoclonal Antibodies Episode 372: Pharmacology 101: Proteasome Inhibitors ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments New Multiple Myeloma Treatments Present New Challenges in Side Effect Management Reduce Racial Barriers and Care Inequities for Black and African American Patients With Multiple Myeloma ONS Voice FDA approval alerts ONS Voice oncology drug reference sheets: Belantamab mafodotin-blmf Daratumumab Motixafortide Selinexor Clinical Journal of Oncology Nursing articles: Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum article: Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS books: Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice (third edition) Multiple Myeloma: A Textbook for Nurses (third edition) ONS course: ONS Hematopoietic Stem Cell Transplantation™ ONS Huddle Cards: Financial Toxicity Hematopoietic Stem Cell Transplantation (HSCT) Monoclonal Antibodies ONS Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library American Society of Clinical Oncology (ASCO)–Ontario Health: Treatment of Multiple Myeloma Living Guideline International Myeloma Foundation: Clinical Trials Fact Sheets Clinical Trial Support Resource Library Multiple Myeloma Research Foundation resource: Treatments for Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Typically for our first-line therapies, we use certain classes of drugs and some of them are proteasome inhibitors like bortezomib and carfilzomib. We also have IMiDs or immunomodulatory agents like thalidomide, lenalidomide, and pomalidomide. We have monoclonal antibodies, anti-CD38 monoclonal antibodies. Of course, we can never talk about treatment for myeloma without mentioning dexamethasone. It is an integral part of our treatment regimen. Most of our frontline therapies now are not just a single agent. They're not even doublets anymore. Typically, they're triplet therapies. And now in 2026, it's leaning more toward quadruplet therapies. By that, I mean you're taking a proteasome inhibitor, an immunomodulatory drug, dexamethasone, and an anti-CD38 monoclonal antibody all together to present patients with a good chance their induction therapy will lead to a good chance of them responding to treatment." TS 4:25 "[With] myeloma labs, there should be some indication after each cycle of therapy that the treatment is working. So, you don't have to do a whole myeloma panel, but maybe getting a monoclonal protein spike, maybe getting a free light chain assay, or maybe an immunoglobulin G or immunoglobulin A level, just to see if the treatment is working. So, those labs are crucial to determine whether the therapies are working. And again, the lab improvements usually correlate with the clinical presentation of the patient." TS 11:01 "There are active clinical trials ongoing with drugs like cell mods. Cell mods are the new oral anticancer agents for myeloma that have shown great promise with efficacy and safety profiles. And then there are other combinations that are showing a lot of promise. So, drugs that are already approved by the U.S. Food and Drug Administration (FDA). And I'm talking about pairing anti-CD38 monoclonal antibodies with bispecific T-cell engagers. If you do that, there has been some evidence that these combinations are very efficacious and responses are durable. And there are ongoing clinical trials and studies being done right now to see if these can be FDA-approved to pinpoint where they are as far as in comparison to other treatments." TS 20:10 "I always tell patients to try to participate in safe, and I want to stress safe, physical activity. So, I tell patients, the more you sit on the couch or you sit in the chair for most of the day, that unfortunately will make your pain worse. So, trying to get up and about and doing some physical activity, such as getting a physical therapy evaluation and a treatment program, no matter how passive or mild or gentle it is, can really help these patients with bone pain." TS 26:10 "I think it's important to realize that myeloma has had amazing advances in science, research and treatments. I think that all of these things coming together, all the science and clinical trials and everything like that, has led to a significant increase in overall survival of our patients, which ultimately is a great thing. We want patients to live longer and they're living longer with a very good quality of life. So, I think it's important to realize that myeloma is very well studied, very well researched, and it's still ongoing with many, many clinical trials." TS 36:04

A Fair Exchange ep. 812 Antony Paschos is a Greek author with short stories in Interzone, Galaxy's Edge, ZNB Presents, Giganotosaurus, James Gunn's Ad Astra, and other magazines.  His short story collection: The Brother's Inheritance was shortlisted for the Greek National Literature Award and the Anagnostis Prize for Literature.  He has published four books in Greek, one novel in French and the novella: It's You, Isn't it? in English from Space Wizard Science Fantasy Books. His work has been translated into five more languages. He is a member of the Athens Club of Science Fiction, and lives in Athens.   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords  

"Depressingly timely" is one way of looking at Luigi Bazzoni's 1971 corker The Fifth Cord/Giornata nera per l'ariete, and not just because it's partly set on New Year's Eve. CW: Violence, gendered violence, sexual abuse of minors, problematic portrayals of LGBTIQ+ characters. Copyright © 2026 David Thomas and Jon Dear Availability on disc and streaming: Blu-ray.com Our theme music:Silent Night (Dark Piano Version) by myuu Creative Commons — Attribution 3.0 Unported— CC BY 3.0Free Download/Stream Music promoted by Audio Library Giallo Reading ListLa Dolce Morte: Vernacular Cinema and the Italian Giallo Film by Mikel J. Koven Italian Giallo in Film and Television: A Critical History by Roberto Curti So Deadly, So Perverse: 50 Years of Italian Giallo Films by Troy HowarthVolume 1: 1963-1973Volume 2: 1974-2013Volume 3: Giallo-Style Films From Around the World Mario Bava: All the Colours of the Dark by Tim Lucas Dario Argento: The Man, the Myths & the Magic by Alan Jones All the Colours of Sergio Martino by Kat Ellinger Beyond Terror: The Films of Lucio Fulci by Stephen Thrower Human Beasts: The Films of Paul Naschy by Troy Howarth Italian Horrors: Cannibals, Zombies, Strange Vices and Guilty Pleasures! edited by Allan Bryce Make Them Die Slowly: The Kinetic Cinema of Umberto Lenzi by Troy Howarth

Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast

The party has no choice but to resort to violence within the Cradle of Lamashtu.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send us a text

Nighthawks ep. 811 Roger Ley has self-published eight novels and one anthology of speculative stories. He was born and educated mainly in London, but spent some of his formative years in Saudi Arabia. Later, he worked as an engineer in the oilfields of North Africa and in the North Sea before starting a career in higher education teaching computer-aided engineering. His early articles appeared in publications including The Guardian, Reader's Digest, The Oldie, and Best of British. His short stories have been published on a multiplicity of websites and broadcast on BBC Radio. He lives in Suffolk (UK). Visit his website at rogerley.co.uk His Amazon author page is at https://www.amazon.com/stores/Roger-Ley/author/B01KOVZFHM More TTV Stories by Roger ley: https://talltaletv.com/tag/roger-ley/   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords  

S6E1 Retail Media's New Reality: DSP Shifts, Agentic Commerce & Brand Strategy for 2026Season 6 of The Retail Razor Show kicks off with a deep dive into one of the most important topics in commerce today: retail media. Ricardo and Casey sit down with Jeff Cohen, Chief Business Development Officer at Skai, to unpack the newly released 2026 State of Retail Media Report, created in partnership with Stratably.This episode explores how brands, versus retailers, are navigating the rapid evolution of retail media. From DSP shifts and CTV growth to AI adoption and agentic commerce, measurement challenges, and the widening gap between leaders and laggards, this conversation delivers the insights every brand marketer needs heading into 2026.What We CoverWhy retail media now commands nearly 30% of US digital ad spendThe rise of retail media maturity and what separates leaders from laggardsWhy organizational structure is now a top predictor of retail media successThe growing importance of Amazon DSP and Amazon Marketing Cloud (AMC)How brands should evaluate incrementality, attribution, and ROIWhy CTV and sponsored brand video are acceleratingThe role of AI and agentic commerce in shaping future shopping journeysWhat brands must do in 2026 to stay competitiveDownload the 2026 State of Retail Media Report (free):https://skai.io/reports-and-whitepapers/2026-state-of-retail-media-report/Subscribe to the Retail Razor Podcast Network: https://retailrazor.com/Subscribe to our Newsletter: https://retailrazor.substack.comSubscribe to our YouTube channel: https://bit.ly/RRShowYouTubeAbout our GuestsJeff Cohen, Chief Business Development Officer, Skaihttps://www.linkedin.com/in/jeffreycohen/Jeff Cohen leads global business development at Skai, overseeing partnerships and innovation across the commerce media ecosystem. A recognized thought leader, he is focused on uniting brands, agencies, retailers, and publishers around the next era of growth. Previously, Jeff was Principal Evangelist at Amazon Ads.Chapters:00:00 Preview Teaser 00:53 Show Intro 03:45 Welcome Jeff Cohen 06:24 Retail Media Maturity and Brand Strategies 08:30 Leaders vs. Laggards in Retail Media 12:12 Organizational Structure and Retail Media Success 17:35 Amazon Ads and DSP Insights 24:36 Evaluating Performance Across Platforms 27:45 The Shift to Full Funnel Advertising 29:46 Challenges in Measurement and Attribution 30:50 The Role of AMC in Retail Media 33:01 Incrementality and Budget Constraints 35:45 AI's Impact on Retail Media 37:10 Strategies for Brands in an AI World 42:54 Key Takeaways and Final Thoughts 48:21 Show CloseMeet your hosts, helping you cut through the clutter in retail & retail tech:Ricardo Belmar is an NRF Top Retail Voice for 2025 and a RETHINK Retail Top Retail Expert from 2021 – 2026. Thinkers 360 has named him a Top 10 Thought Leader in Retail and AGI, a Top 50 Thought Leader in Management, Careers, and Transformation, and a Top 100 Thought Leader in Agentic AI and Digital Transformation. Thinkers 360 also named him a Top Digital Voice for 2024 and 2025. He is an advisory council member at George Mason University's Center for Retail Transformation and the Retail Cloud Alliance. He was most recently the partner marketing leader for retail & consumer goods in the Americas at Microsoft.Casey Golden is the North America Leader for Retail & Consumer Goods at CI&T, and CEO of Luxlock. She is a RETHINK Retail Top Retail Expert from 2023 - 2026, and Retail Cloud Alliance advisory council member. After a career on the fashion and supply chain technology side of the business, Casey is obsessed with the customer relationship between the brand and the consumer and is slaying franken-stacks and building retail tech! Includes music provided by imunobeats.com, featuring Overclocked, and E-Motive from the album Beat Hype, written by Heston Mimms, published by Imuno.

What does “cashless bail” really mean, and why is the federal government suddenly taking notice. From Rikers Island to reform efforts in New Jersey and New York, pretrial detention affects more lives than most people realize, often punishing individuals before trial. In this episode, Dr. Kellen Funk explains why bail is not just a legal technicality — it's a societal issue that shapes justice, equity, and everyday life.

"Radioimmunoconjugates work through a dual mechanism that combines immunologic targeting with localized radiation delivery. The monoclonal antibody components bind to specific tumor-associated antigens such as CD20, expressed on malignant B cells. Once found, the attached radioisotope delivers beta radiation directly to the tumor, causing DNA damage and cell death," Sabrina Enoch, MSN, RN, OCN®, CNMT, NMTCB (CT), theranostics clinical specialist at Highlands Oncology in Rogers, AR, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radioimmunoconjugates. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 30, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge in the history of, the mechanism of action of, and the use of radioimmunoconjugates in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 377: Creating and Implementing Radiopharmaceutical Policies and Procedures Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles ONS Voice articles: Interprofessional Collaboration Reduces Time to Neutropenia Antibiotic Administration Radiopharmaceuticals and Theranostics Offer New Options for Oncology Nurses to Transform Cancer Care Radiopharmaceuticals Pack a One-Two Punch Against Cancer Safety Is Key in Use of Radiopharmaceuticals Telehealth Has Value During Radiotherapy, Patients Say ONS Voice oncology drug reference sheets: Lutetium Lu 177 dotatate Lutetium Lu 177 vipivotide tetraxetan Radium 223 dichloride Sodium iodide-131 Strontium chloride Sr-89 ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Chemotherapy Immunotherapy Certificate™ ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Radiopharmaceutical Safety: Making It Easy Targeted Radionuclide Therapy: A Theranostic Approach to Cancer Therapy ONS Huddle Cards: Radiobiology Radiopharmaceuticals ONS Learning Libraries: Immuno-Oncology Radiation ONS Symptom Interventions for Prevention of Bleeding Drugs@FDA package inserts To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Radioimmunoconjugates are a specialized subset of radiopharmaceuticals designed to combine the specificity of monoclonal antibodies with the cytotoxic power of radiation. ... Early development focused on B-cell malignancies, particularly non-Hodgkin lymphoma." TS 1:51  "An important concept for nurses to understand is the crossfire effect, where radiation can affect nearby tumor cells, even though not every cell expressed has the target antigen. This helps explain why these agents can be effective even in heterogeneous tumors." TS 3:40 "At present, 90 Y-ibritumomab tiuxetan is the only radioimmunoconjugate approved by the U.S. Food and Drug Administration (FDA) in clinical use. Historically, iodine-131 tositumomab played a major role in establishing these therapy classes, but it's also useful to contrast radioimmunoconjugates with other radiopharmaceuticals, such as iodine-131 therapies, which a lot of places do at this time, used for thyroid diseases, or radium 223, used for metastatic prostate cancer. Unlike those agents, radioimmunoconjugates rely on antibody-mediated targeted rather than physiologic uptake or bone affinity." TS 4:55 "I just try to explain to [patients] that radiation exposure is like being next to a flame. The further you are away, the less heat you get, the less exposure you get. These patients can be radioactive for three days, seven days—it just depends on how fast they excrete it through their bodies with half-life exposure." TS 9:33 "While only one agent is currently approved, the principles established by radioimmunoconjugates continue to guide development for newer targeted radiopharmaceuticals. Emerging agents aim to improve targeting, reduce toxicity, and expand indications beyond hematologic malignancies. This evolution underscores the importance of nursing education in this rapidly changing field." TS 10:41 "Radioimmunoconjugates represent an important bridge between traditional oncology treatments and the future of targeted therapies. Oncology nurses play a vital role in ensuring safe delivery, patient understanding, and collaboration between multidisciplinary teams. So, it's very important to educate and also stay up to date on evidence-based practices." TS 13:12

The Academy Award nominations are out and hosts Kevin Schwaller and Ema Sasic have some thoughts! They talk surprises, snubs and more. The Oscars aren't until March 15, though, so... we have a long way to go. Buckle up!Disclaimer:Copyright notice:(Intro/outro) She's The Greatest Dancer by Ryan Andersen is licensed under a Attribution-NonCommercial License. https://freemusicarchive.org/music/Ryan_Andersen/MORE/Shes_The_Greatest_Dancer?fbclid=IwAR1TDCO9eT6TxmDrTaJr9HRQVk2gUu00cNXeG8oik3avXVEhbSGqsqUfLkoCopyright notice:(Break) Extremely Tik-tok compatible for slow videos by Lundstroem is licensed under a Attribution 4.0 International License. https://freemusicarchive.org/music/lundstroem/the-happiest-songs/extremely-tik-tok-compatible-for-slow-videos/

Dr. Carl Jung wrote that around the age of 35 we enter "the shadow side of life". Nowadays we call it a midlife crisis, but to Jung, it's a call from the depths of your soul—an invitation for the journey inward. Will you answer the call?Support my work and the Creative Codex vision on Patreon, where you can gain access to my Red Book Reading series, along with all my Creativity Tip minisodes, the Jim Morrison and Kurt Cobain series: https://www.patreon.com/mjdorian∞∞∞∞∞Note on the imagery used in the video: Attribution for artworks appears in the lower right hand corner onscreen. The imagery shown during Jung's vision segments was made with Midjourney. All other imagery, such as the artworks shown when discussing Jung's physical Red Book, are the original documents & artworks.∞∞∞∞∞Written & Produced by MJDorianAll music by MJDorian

Find Merch here: https://theirrelevant.org/store Join The El Pochcast Discord here: https://discord.gg/AS8RuMHsxJ Bluesky: @elpochcast.pocho.online Instagram: @elpochcast Email : elpochcast@ gmail.com Text: www.pocho.online El Pochcast is a part of The Irrelevant Podcast Network rapture.mp3 by Vincent Augustus is licensed under a Attribution 4.0 International License. https://creativecommons.org/licenses/by/4.0/ Support El Pochcast by contributing to their tip jar: https://tips.pinecast.com/jar/el-pochcast

Jyoti Pannu, Product Manager at Booking.com, shares how AI is transforming the way travelers discover, plan, and book their next adventure. From AI trip planners that surface new possibilities to the integration of GenAI and ChatGPT into the core product, Jyoti explains why travel discovery is moving beyond simple search, how user intent is now mapped through nuanced signals, and what the rise of LLMs means for attribution, retention, and the future of app UX. She also dives into cross-vertical product lessons, balancing novelty and personalization, and offers advice for elevating women in product management.Questions addressed in this episode:What is Booking.com, and what does Jyoti's role cover?How is AI being used at Booking.com beyond chatbots and content generation?What does intent-based and natural language discovery look like in practice?How is the app experience changing with AI-driven trip planners and smart filters?How does Booking.com balance user personalization and novelty in recommendations?How do LLM-based discovery channels affect paid UA and retargeting strategies?What guardrails and metrics are important for launching new AI features?What lessons cross over from fintech, e-commerce, and travel in app retention?How should product teams think about post-purchase and post-trip experience?What advice does Jyoti have for women building a career in product and tech?Timestamps:(0:03) – Jyoti's role at Booking.com and scope of the app(1:39) – AI trip planners and intent-driven product development(3:17) – Smart filters and natural language input for hotel discovery(4:03) – How Booking.com infers trip purpose and personalizes UX(6:09) – LLMs, ChatGPT, and new search/discovery interfaces(8:13) – Attribution, channel mix, and UA economics in an AI-first world(11:01) – Avoiding the filter bubble in travel recommendations(13:41) – Booking.com plugins and booking via ChatGPT(15:41) – Cross-vertical product lessons from e-commerce, fintech, and travel(17:58) – Brand omnipresence, loyalty, and retention(19:04) – Emotional stakes and UX in travel vs. transactional apps(21:37) – Post-trip and post-purchase: product touchpoints(22:50) – Testing AI features for retention and quality(24:24) – Guardrails, review, and data governance(25:29) – Elevating women in product and leadership(27:50) – Rapid-fire: travel, career, life, and favorite placesQuotes:(3:35) “We have an option for users called smart filters, where they can make searches in the form of natural language, like how you would interact with a human. We map this in our systems to provide personalized results for these users.”(17:00) “If a user has interacted with our platform and they have made a purchase from two different categories, they are more likely to become a high value customer than someone who has bought multiple times in the same category.”Mentioned in This Episode:Jyoti Pannu on LinkedInBooking.com

You asked, we're answering. In this listener Q&A episode, Amber and Carolyn tackle the hard questions GTM leaders are wrestling with behind closed doors…from broken attribution models to navigating organizational resistance when you're trying to drive real change.In this episode:Real talk on entrepreneurship: the wins, the loneliness, and knowing when to walk awayNavigating organizational resistance when you're championing changeWhy being in the top 5% of GTM leaders means accepting you're always pushing uphillWhy first-touch and last-touch attribution keep haunting you (and how to finally escape)How to get executive buy-in when everyone's comfortable with the status quoWhy deals from different sources have wildly different ACVs and win ratesThe systematic reality of revenue generation, and why singular attribution models completely miss itThis isn't surface-level advice. Amber and Carolyn are in the trenches daily with CROs, CMOs and RevOps leaders, rearchitecting go-to-market strategies and challenging sacred cows. We're bringing real examples to this convo, honest reflections about entrepreneurship, and zero sugarcoating about what separates companies that evolve from those that don't.Keep sending your questions. We want to hear your hot takes, especially if you disagree with what we're saying.

Sirio distracts the cultists while Mitch and Drei explore the cavern.WebsiteDiscordTwitterPathfinder Second Edition and the Kingmaker Adventure Path are published by Paizo."Take the Lead" and other featured music were composed by Kevin MacLeod and licensed under Creative Commons by: Attribution 4.0 License.All ambiances were composed by Michael Ghelfi Studios.The Zero Check are committed to providing an inclusive and respectful experience to all listeners, but we also recognize and acknowledge that we are limited by our individual frames of reference. If we misstep, please let us know. Email all feedback to feedback@zerocheckpodcast.com.Thank you for listening to The Zero Check. Send us a text

"The United States does not have a national cancer registry. We have a bunch of state registries. Some of those registries do collaborate and share information, but the issue is the registries that do exist typically do not report cancer by occupation. So, we cannot get our arms around the potential work-relatedness of the health outcome given the current way the state registries collect information. What we're trying to set up, is a way to make what is currently an invisible risk, visible," ONS member Melissa McDiarmid, MD, MPH, DABT, professor of medicine and epidemiology and public health director of the division of occupational and environmental medicine at the University of Maryland School of Medicine in Baltimore, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the University of Maryland School of Medicine Hazardous Drug Safety Center Exposure Registry. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 23, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge in the incidence of hazardous drug exposure and the tracking and reporting of healthcare worker exposures. Episode Notes  Complete this evaluation for free NCPD. University of Maryland School of Medicine Hazardous Drug Safety Center Exposure Registry information sheet ONS Podcast™ episodes: Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 308: Hazardous Drugs and Hazardous Waste: Personal, Patient, and Environmental Safety Episode 209: Updates in Chemo PPE and Safe Handling ONS Voice articles: Hazardous Drug Surface Contamination Prevails, Despite More Diligent PPE National Hazardous Drug Exposure Registry Safeguards Oncology Professionals NIOSH Releases Its 2024 List of Hazardous Drugs Safe Handling—We've Come a Long Way, Baby! Strategies to Promote Safe Medication Administration Practices Surfaces in Patient Bathrooms Often Contaminated With HDs, Despite Use of Plastic-Backed Pads ONS books: Safe Handling of Hazardous Drugs (fourth edition) Safe Handling of Hazardous Drugs Quick Guide™ ONS course: Safe Handling Basics Clinical Journal of Oncology Nursing articles: Hazardous Drug Exposure: Case Report Analysis From a Prospective, Multisite Study of Oncology Nurses' Exposure in Ambulatory Settings Personal Protective Equipment Use and Surface Contamination With Antineoplastic Drugs: The Impact of the COVID-19 Pandemic Sequential Wipe Testing for Hazardous Drugs: A Quality Improvement Project The Use of Plastic-Backed Pads to Reduce Hazardous Drug Contamination Oncology Nursing Forum articles: Ensuring Healthcare Worker Safety When Handling Hazardous Drugs Factors Influencing Nurses' Use of Hazardous Drug Safe Handling Precautions Other ONS resources: ONS Safe Handling of Hazardous Drugs Quick Guide Introduction to Safe Handling Huddle Card Safe Handling of Hazardous Drugs Learning Library Hematology/Oncology Pharmacy Association (HOPA) course: Safe Handling of Hazardous Drugs National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings, 2024 To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We thought that in order to answer some of the unclear questions about health risk, we would set up an exposure registry, in this case, for oncology personnel who handle the drugs. This would then create a cohort that we could ask questions to. For example, we could try to characterize whether there is a cancer excess in this group. Or characterize the reproductive abnormalities in excess that people are experiencing." TS 6:21 "It's sort of counterintuitive that the healthcare industry, whose mission itself is care of the sick, is a high-hazard industry. We typically think about the risk as being from infectious diseases, and certainly we've all lived in our practice lifetime through some examples of that. Even before COVID-19, some of us were doing preparation for Ebola and that sort of thing. So, we're kind of used to that. But the hazards that you kind of grew up with, we've routinized or normalized handling group one, human carcinogens, which a number of these drugs are—it's just something we do every day. Well, it is, but we have to do it with respect and with care every day. And I think sometimes in that routineness of it, we have sort of lost sight of the vigilance that we need to maintain." TS 11:19 "It's very easy in the life cycle of a drug in an organization to do something that doesn't just impact you, but unknowingly, you've contaminated a surface for somebody who comes behind you. Who maybe doesn't have plastic protective equipment on because something that got contaminated shouldn't have been contaminated in the first place. If we could all be thinking of it as more of a team sport, especially in terms of safe handling, that our disposition and drug handling affects not just us and our health, but those of our colleagues." TS 24:47 "For the job history pieces, we ask what year you started, what year you stopped, and we ask about estimations of handling. So we'll be able to come up with either a duration or some kind of metric for the intensity and duration of your handling history, which will then permit us to sort the population who completed the survey into sort of low, medium, high. And we'll see whether the health outcomes that are being reported are influenced by that drug handling history." TS 27:45 "The idea that we aren't exposed to the same therapeutic dose we give to our patients is absolutely true. However, the dosing schedule to them versus us is very different, and we are exposed frequently, if not daily, to very small concentrations. They don't reach a cytotoxic dose necessarily, but we do know from a lot of studies that either ourselves or our colleagues are taking up drug from contaminated work environments. And you've probably seen there is an awful lot of intermediate evidence looking at genotoxic insult in pharmacists and nurses who handle the drugs. So clearly we're showing uptake and we're showing that there are biologically plausible, concerning measures that are taking place in us. So, I think that we need to come back and circle around the idea that we need to have deep respect for the toxicity of these agents." TS 35:03

Cadillac ep. 810 Shawn Brink (writing under Shawn D. Brink and Shawn David Brink) resides in Eastern Nebraska, U.S.A. and is represented by Liverman Literary Agency. He's building a following with a growing list of novels (mainly speculative fiction), as well as shorter works published in various publications and anthologies. His seventh novel 'The Tunnel Rat' is currently under contract consideration through Tell-Tale Publishing Group. Check out his website to learn more: https://shawnbrinkauthor.wordpress.com/.   ---- Listen Elsewhere ---- YouTube:  https://www.youtube.com/c/TallTaleTV Website: http://www.TallTaleTV.com   ---- Story Submission ---- Got a short story you'd like to submit? Submission guidelines can be found at http://www.TallTaleTV.com   ---- About Tall Tale TV ---- Hi there! My name is Chris Herron and I'm an audiobook narrator. In 2015, I suffered from poor Type 1 diabetes control which lead me to become legally blind for almost a year. The doctors didn't give me much hope, predicting an 80% chance that I would never see again. But I refused to give up and changed my lifestyle drastically. Through sheer willpower (and an amazing eye surgeon) I beat the odds and regained my vision. During that difficult time, I couldn't read or write, which was devastating as they had always been a source of comfort for me since childhood. However, my wife took me to the local library where she read out the titles of audiobooks to me. I selected some of my favorite books, such as the Disc World series, Name of the Wind, Harry Potter, and more, and the audiobooks brought these stories to life in a way I had never experienced before. They helped me through the darkest period of my life and I fell in love with audiobooks. Once I regained my vision, I decided to pursue a career as an audiobook narrator instead of a writer. That's why I created Tall Tale TV, to support aspiring authors in the writing communities that I had grown to love before my ordeal. My goal was to help them promote their work by providing a promotional audio short story that showcases their writing skills to readers. They say the strongest form of advertising is word of mouth, so I offer a platform for readers to share these videos and help spread the word about these talented writers. Please consider sharing these stories with your friends and family to support these amazing authors. Thank you!   ---- legal ---- All stories on Tall Tale TV have been submitted in accordance with the terms of service provided on http://www.talltaletv.com or obtained with permission by the author. All images used on Tall Tale TV are either original or Royalty and Attribution free. Most stock images used are provided by http://www.pixabay.com , https://www.canstockphoto.com/ or created using AI. Image attribution will be declared only when required by the copyright owner. Common Affiliates are: Amazon, Smashwords